{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T22:26:17Z","timestamp":1783117577688,"version":"3.54.6"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T00:00:00Z","timestamp":1726012800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T00:00:00Z","timestamp":1726012800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"DOI":"10.1186\/s12964-024-01813-5","type":"journal-article","created":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T08:27:49Z","timestamp":1726043269000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["A novel amphiphilic squalene-based compound with open-chain polyethers reduces malignant melanoma metastasis in-vitro and in-vivo"],"prefix":"10.1186","volume":"22","author":[{"given":"Yaman","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meriem","family":"Bejaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tran Ngoc","family":"Linh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Arimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroko","family":"Isoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,11]]},"reference":[{"key":"1813_CR1","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3390\/medsci9040063","volume":"9","author":"K Saginala","year":"2021","unstructured":"Saginala K, Barsouk A, Aluru JS, Rawla P, Barsouk A. Epidemiology of Melanoma Medical Sciences. 2021;9:63.","journal-title":"Epidemiology of Melanoma Medical Sciences"},{"key":"1813_CR2","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.advenzreg.2010.09.005","volume":"51","author":"D Gil","year":"2011","unstructured":"Gil D, Cio\u0142czyk-Wierzbicka D, Duli\u0144ska-Litewka J, \u017bwawa K, McCubrey JA, Laidler P. The mechanism of contribution of integrin linked kinase (ILK) to epithelial-mesenchymal transition (EMT). Adv Enzyme Regul. 2011;51:195\u2013207.","journal-title":"Adv Enzyme Regul"},{"key":"1813_CR3","first-page":"2520","volume":"55","author":"S Koop","year":"1995","unstructured":"Koop S, MacDonald IC, Luzzi K, Schmidt EE, Morris VL, Grattan M, et al. Fate of Melanoma Cells Entering the Microcirculation: Over 80% Survive and Extravasate1. Can Res. 1995;55:2520\u20133.","journal-title":"Can Res"},{"key":"1813_CR4","doi-asserted-by":"crossref","unstructured":"Nicolson GL. Cancer metastasis: Organ colonization and the cell-surface properties of mallignant cells. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1982;695:113\u201376.","DOI":"10.1016\/0304-419X(82)90020-8"},{"key":"1813_CR5","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1053\/j.seminoncol.2007.09.009","volume":"34","author":"GH Mahabeleshwar","year":"2007","unstructured":"Mahabeleshwar GH, Byzova TV. Angiogenesis in Melanoma. Semin Oncol. 2007;34:555\u201365.","journal-title":"Semin Oncol"},{"key":"1813_CR6","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.cell.2010.03.015","volume":"141","author":"K Kessenbrock","year":"2010","unstructured":"Kessenbrock K, Plaks V, Werb Z. Matrix Metalloproteinases: Regulators of the Tumor Microenvironment. Cell. 2010;141:52\u201367.","journal-title":"Cell"},{"key":"1813_CR7","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1046\/j.1523-1747.2000.00068.x","volume":"115","author":"UB Hofmann","year":"2000","unstructured":"Hofmann UB, Westphal JR, van Muijen GNP, Ruiter DJ. Matrix Metalloproteinases in Human Melanoma. J Investig Dermatol. 2000;115:337\u201344.","journal-title":"J Investig Dermatol"},{"key":"1813_CR8","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.phrs.2009.01.017","volume":"59","author":"S Nobili","year":"2009","unstructured":"Nobili S, Lippi D, Witort E, Donnini M, Bausi L, Mini E, et al. Natural compounds for cancer treatment and prevention. Pharmacol Res. 2009;59:365\u201378.","journal-title":"Pharmacol Res"},{"key":"1813_CR9","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1002\/ptr.5928","volume":"31","author":"T-H Kang","year":"2017","unstructured":"Kang T-H, Yoon G, Kang I-A, Oh H-N, Chae J-I, Shim J-H. Natural Compound Licochalcone B Induced Extrinsic and Intrinsic Apoptosis in Human Skin Melanoma (A375) and Squamous Cell Carcinoma (A431) Cells. Phytother Res. 2017;31:1858\u201367.","journal-title":"Phytother Res"},{"key":"1813_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0090783","volume":"9","author":"M Sztiller-Sikorska","year":"2014","unstructured":"Sztiller-Sikorska M, Koprowska K, Majchrzak K, Hartman M, Czyz M. Natural Compounds\u2019 Activity against Cancer Stem-Like or Fast-Cycling Melanoma Cells. PLoS ONE. 2014;9: e90783.","journal-title":"PLoS ONE"},{"key":"1813_CR11","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.ejphar.2014.11.011","volume":"746","author":"C-H Huang","year":"2015","unstructured":"Huang C-H, Lu S-H, Chang C-C, Thomas PA, Jayakumar T, Sheu J-R. Hinokitiol, a tropolone derivative, inhibits mouse melanoma (B16\u2013F10) cell migration and in vivo tumor formation. Eur J Pharmacol. 2015;746:148\u201357.","journal-title":"Eur J Pharmacol"},{"key":"1813_CR12","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1002\/JLB.3MR0320-444R","volume":"108","author":"L-J Deng","year":"2020","unstructured":"Deng L-J, Qi M, Li N, Lei Y-H, Zhang D-M, Chen J-X. Natural products and their derivatives: Promising modulators of tumor immunotherapy. J Leukoc Biol. 2020;108:493\u2013508.","journal-title":"J Leukoc Biol"},{"key":"1813_CR13","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.phrs.2016.06.018","volume":"111","author":"P Poornima","year":"2016","unstructured":"Poornima P, Kumar JD, Zhao Q, Blunder M, Efferth T. Network pharmacology of cancer: From understanding of complex interactomes to the design of multi-target specific therapeutics from nature. Pharmacol Res. 2016;111:290\u2013302.","journal-title":"Pharmacol Res"},{"key":"1813_CR14","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1271\/bbb.110430","volume":"75","author":"K Kaya","year":"2011","unstructured":"Kaya K, Nakazawa A, Matsuura H, Honda D, Inouye I, Watanabe MM. Thraustochytrid Aurantiochytrium sp. 18W\u201313a Accummulates High Amounts of Squalene. Biosci Biotechnol Biochem. 2011;75:2246\u20138.","journal-title":"Biosci Biotechnol Biochem"},{"key":"1813_CR15","first-page":"29","volume":"4","author":"GS Kelly","year":"1999","unstructured":"Kelly GS. Squalene and its potential clinical uses. Alternative medicine review: a journal of clinical therapeutic. 1999;4:29\u201336.","journal-title":"Alternative medicine review: a journal of clinical therapeutic"},{"key":"1813_CR16","doi-asserted-by":"publisher","first-page":"462","DOI":"10.31989\/ffhd.v3i12.30","volume":"3","author":"AL Ronco","year":"2013","unstructured":"Ronco AL, St\u00e9fani ED. Squalene: a multi-task link in the crossroads of cancer and aging. Functional Foods in Health and Disease. 2013;3:462.","journal-title":"Functional Foods in Health and Disease"},{"key":"1813_CR17","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1093\/carcin\/19.2.287","volume":"19","author":"CV Rao","year":"1998","unstructured":"Rao CV, Newmark HL, Reddy BS. Chemopreventive effect of squalene on colon cancer. Carcinogenesis. 1998;19:287\u201390.","journal-title":"Carcinogenesis"},{"key":"1813_CR18","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1080\/10610278.2021.1970161","volume":"33","author":"TN Linh","year":"2021","unstructured":"Linh TN, Arimura T, Tominaga K, Kigoshi H, Isoda H. Syntheses and aggregation properties of new squalene receptors bearing open chain ligands. Supramol Chem. 2021;33:194\u2013201.","journal-title":"Supramol Chem"},{"key":"1813_CR19","doi-asserted-by":"publisher","first-page":"W216","DOI":"10.1093\/nar\/gkac194","volume":"50","author":"BT Sherman","year":"2022","unstructured":"Sherman BT, Hao M, Qiu J, Jiao X, Baseler MW, Lane HC, et al. DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update). Nucleic Acids Res. 2022;50:W216\u201321.","journal-title":"Nucleic Acids Res"},{"key":"1813_CR20","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","volume":"10","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, Zhou B, Pache L, Chang M, Khodabakhshi AH, Tanaseichuk O, et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 2019;10:1523.","journal-title":"Nat Commun"},{"key":"1813_CR21","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1016\/j.semcancer.2015.02.006","volume":"35","author":"MA Feitelson","year":"2015","unstructured":"Feitelson MA, Arzumanyan A, Kulathinal RJ, Blain SW, Holcombe RF, Mahajna J, et al. Sustained proliferation in cancer: Mechanisms and novel therapeutic targets. Semin Cancer Biol. 2015;35:S25\u201354.","journal-title":"Semin Cancer Biol"},{"key":"1813_CR22","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9","volume":"182","author":"T Scholzen","year":"2000","unstructured":"Scholzen T, Gerdes J. The Ki-67 protein: from the known and the unknown. J Cell Physiol. 2000;182:311\u201322.","journal-title":"J Cell Physiol"},{"key":"1813_CR23","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.abb.2014.06.028","volume":"563","author":"N Theodosakis","year":"2014","unstructured":"Theodosakis N, Micevic G, Kelly DP, Bosenberg M. Mitochondrial function in melanoma. Arch Biochem Biophys. 2014;563:56\u20139.","journal-title":"Arch Biochem Biophys"},{"key":"1813_CR24","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.ab.2017.07.009","volume":"552","author":"LD Zorova","year":"2018","unstructured":"Zorova LD, Popkov VA, Plotnikov EY, Silachev DN, Pevzner IB, Jankauskas SS, et al. Mitochondrial membrane potential. Anal Biochem. 2018;552:50\u20139.","journal-title":"Anal Biochem"},{"key":"1813_CR25","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1083\/jcb.201102147","volume":"196","author":"P Lu","year":"2012","unstructured":"Lu P, Weaver VM, Werb Z. The extracellular matrix: A dynamic niche in cancer progression. J Cell Biol. 2012;196:395\u2013406.","journal-title":"J Cell Biol"},{"key":"1813_CR26","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41571-021-00549-2","volume":"19","author":"R Dhanasekaran","year":"2022","unstructured":"Dhanasekaran R, Deutzmann A, Mahauad-Fernandez WD, Hansen AS, Gouw AM, Felsher DW. The MYC oncogene \u2014 the grand orchestrator of cancer growth and immune evasion. Nat Rev Clin Oncol. 2022;19:23\u201336.","journal-title":"Nat Rev Clin Oncol"},{"key":"1813_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.593195","volume":"11","author":"L Shen","year":"2020","unstructured":"Shen L, Chen Q, Yang C, Wu Y, Yuan H, Chen S, et al. Role of PRDM1 in tumor immunity and drug response: a pan-cancer analysis. Front Pharmacol. 2020;11: 593195.","journal-title":"Front Pharmacol"},{"key":"1813_CR28","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1002\/1097-0142(19940415)73:8<2013::AID-CNCR2820730802>3.0.CO;2-J","volume":"73","author":"JFR Kerr","year":"1994","unstructured":"Kerr JFR, Winterford CM, Harmon BV. Apoptosis. Its significance in cancer and cancer Therapy. Cancer. 1994;73:2013\u201326.","journal-title":"Cancer."},{"key":"1813_CR29","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1126\/science.1115035","volume":"311","author":"SA Lakhani","year":"2006","unstructured":"Lakhani SA, Masud A, Kuida K, Porter GA, Booth CJ, Mehal WZ, et al. Caspases 3 and 7: Key Mediators of Mitochondrial Events of Apoptosis. Science. 2006;311:847\u201351.","journal-title":"Science"},{"key":"1813_CR30","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/s41580-018-0089-8","volume":"20","author":"R Singh","year":"2019","unstructured":"Singh R, Letai A, Sarosiek K. Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins. Nat Rev Mol Cell Biol. 2019;20:175\u201393.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1813_CR31","volume":"2012","author":"TR Velho","year":"2012","unstructured":"Velho TR. Metastatic melanoma \u2013 a review of current and future drugs. Drugs Context. 2012;2012: 212242.","journal-title":"Drugs Context"},{"key":"1813_CR32","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1039\/C5TB02053K","volume":"4","author":"SA Senevirathne","year":"2016","unstructured":"Senevirathne SA, Washington KE, Biewer MC, Stefan MC. PEG based anti-cancer drug conjugated prodrug micelles for the delivery of anti-cancer agents. J Mater Chem B. 2016;4:360\u201370.","journal-title":"J Mater Chem B"},{"key":"1813_CR33","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1517\/17425255.2014.967679","volume":"10","author":"X Zhang","year":"2014","unstructured":"Zhang X, Wang H, Ma Z, Wu B. Effects of pharmaceutical PEGylation on drug metabolism and its clinical concerns. Expert Opin Drug Metab Toxicol. 2014;10:1691\u2013702.","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"1813_CR34","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1016\/S0022-2275(20)42347-8","volume":"31","author":"T Strandberg","year":"1990","unstructured":"Strandberg T, Tilvis R, Miettinen T. Metabolic variables of cholesterol during squalene feeding in humans: comparison with cholestyramine treatment. J Lipid Res. 1990;31:1637\u201343.","journal-title":"J Lipid Res"},{"key":"1813_CR35","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s10585-012-9457-5","volume":"29","author":"D Spano","year":"2012","unstructured":"Spano D, Zollo M. Tumor microenvironment: a main actor in the metastasis process. Clin Exp Metastasis. 2012;29:381\u201395.","journal-title":"Clin Exp Metastasis"},{"key":"1813_CR36","first-page":"8221","volume":"63","author":"UB Hofmann","year":"2003","unstructured":"Hofmann UB, Eggert AAO, Blass K, Br\u00f6cker E-B, Becker JC. Expression of Matrix Metalloproteinases in the Microenvironment of Spontaneous and Experimental Melanoma Metastases Reflects the Requirements for Tumor Formation. Can Res. 2003;63:8221\u20135.","journal-title":"Can Res"},{"key":"1813_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2021.786283","volume":"9","author":"D Yu","year":"2021","unstructured":"Yu D, Lai P, Yan T, Fang K, Chen L, Zhang S. Quantifying the Matrix Metalloproteinase 2 (MMP2) Spatially in Tissues by Probe via MALDI Imaging Mass Spectrometry. Front Chem. 2021;9: 786283.","journal-title":"Front Chem"},{"key":"1813_CR38","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.bcp.2015.12.016","volume":"103","author":"CV M\u00f6ser","year":"2016","unstructured":"M\u00f6ser CV, Meissner M, Laarmann K, Olbrich K, King-Himmelreich TS, Wolters MC, et al. The protein kinase IKKepsilon contributes to tumour growth and tumour pain in a melanoma model. Biochem Pharmacol. 2016;103:64\u201373.","journal-title":"Biochem Pharmacol"},{"key":"1813_CR39","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1002\/cam4.2678","volume":"9","author":"M Yin","year":"2020","unstructured":"Yin M, Wang X, Lu J. Advances in IKBKE as a potential target for cancer therapy. Cancer Med. 2020;9:247\u201358.","journal-title":"Cancer Med"},{"key":"1813_CR40","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3390\/cancers14020311","volume":"14","author":"M Zerfaoui","year":"2022","unstructured":"Zerfaoui M, Toraih E, Ruiz E, Errami Y, Attia AS, Krzysztof M, et al. Nuclear Localization of BRAFV600E Is Associated with HMOX-1 Upregulation and Aggressive Behavior of Melanoma Cells. Cancers. 2022;14:311.","journal-title":"Cancers"},{"key":"1813_CR41","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ccell.2018.11.008","volume":"35","author":"P Karras","year":"2019","unstructured":"Karras P, Riveiro-Falkenbach E, Ca\u00f1\u00f3n E, Tejedo C, Calvo TG, Mart\u00ednez-Herranz R, et al. p62\/SQSTM1 Fuels Melanoma Progression by Opposing mRNA Decay of a Selective Set of Pro-metastatic Factors. Cancer Cell. 2019;35:46\u201363.e10.","journal-title":"Cancer Cell"},{"key":"1813_CR42","doi-asserted-by":"publisher","first-page":"52904","DOI":"10.1074\/jbc.M406868200","volume":"279","author":"K Bostr\u00f6m","year":"2004","unstructured":"Bostr\u00f6m K, Zebboudj AF, Yao Y, Lin TS, Torres A. Matrix GLA Protein Stimulates VEGF Expression through Increased Transforming Growth Factor-\u03b21 Activity in Endothelial Cells *. J Biol Chem. 2004;279:52904\u201313.","journal-title":"J Biol Chem"},{"key":"1813_CR43","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.1158\/0008-5472.CAN-18-2098","volume":"80","author":"C Gerarduzzi","year":"2020","unstructured":"Gerarduzzi C, Hartmann U, Leask A, Drobetsky E. The Matrix Revolution: Matricellular Proteins and Restructuring of the Cancer Microenvironment. Can Res. 2020;80:2705\u201317.","journal-title":"Can Res"},{"key":"1813_CR44","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1097\/CMR.0000000000000430","volume":"28","author":"G Ganzetti","year":"2018","unstructured":"Ganzetti G, Sartini D, Campanati A, Rubini C, Molinelli E, Brisigotti V, et al. Nicotinamide N-methyltransferase: potential involvement in cutaneous malignant melanoma. Melanoma Res. 2018;28:82.","journal-title":"Melanoma Res"},{"key":"1813_CR45","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-001388","volume":"9","author":"X Wu","year":"2021","unstructured":"Wu X, Nelson M, Basu M, Srinivasan P, Lazarski C, Zhang P, et al. MYC oncogene is associated with suppression of tumor immunity and targeting Myc induces tumor cell immunogenicity for therapeutic whole cell vaccination. J Immunother Cancer. 2021;9: e001388.","journal-title":"J Immunother Cancer"},{"key":"1813_CR46","doi-asserted-by":"publisher","first-page":"7677","DOI":"10.1038\/s41467-022-35469-x","volume":"13","author":"Q Li","year":"2022","unstructured":"Li Q, Zhang L, You W, Xu J, Dai J, Hua D, et al. PRDM1\/BLIMP1 induces cancer immune evasion by modulating the USP22-SPI1-PD-L1 axis in hepatocellular carcinoma cells. Nat Commun. 2022;13:7677.","journal-title":"Nat Commun"},{"key":"1813_CR47","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1111\/j.1755-148X.2009.00554.x","volume":"22","author":"A Richmond","year":"2009","unstructured":"Richmond A, Yang J, Su Y. The good and the bad of chemokines\/chemokine receptors in melanoma. Pigment Cell Melanoma Res. 2009;22:175\u201386.","journal-title":"Pigment Cell Melanoma Res"},{"key":"1813_CR48","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1158\/0008-5472.CAN-07-2491","volume":"68","author":"KS Hoek","year":"2008","unstructured":"Hoek KS, Eichhoff OM, Schlegel NC, D\u00f6bbeling U, Kobert N, Schaerer L, et al. In vivo Switching of Human Melanoma Cells between Proliferative and Invasive States. Can Res. 2008;68:650\u20136.","journal-title":"Can Res"},{"key":"1813_CR49","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/onc.2017.341","volume":"37","author":"M Perego","year":"2018","unstructured":"Perego M, Maurer M, Wang JX, Shaffer S, M\u00fcller AC, Parapatics K, et al. A slow-cycling subpopulation of melanoma cells with highly invasive properties. Oncogene. 2018;37:302\u201312.","journal-title":"Oncogene"},{"key":"1813_CR50","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1172\/JCI9054","volume":"104","author":"GI Shapiro","year":"1999","unstructured":"Shapiro GI, Harper JW. Anticancer drug targets: cell cycle and checkpoint control. J Clin Invest. 1999;104:1645\u201353.","journal-title":"J Clin Invest"},{"key":"1813_CR51","doi-asserted-by":"publisher","first-page":"953","DOI":"10.4161\/cc.27818","volume":"13","author":"S Yano","year":"2014","unstructured":"Yano S, Miwa S, Mii S, Hiroshima Y, Uehara F, Yamamoto M, et al. Invading cancer cells are predominantly in G0\/G1 resulting in chemoresistance demonstrated by real-time FUCCI imaging. Cell Cycle. 2014;13:953\u201360.","journal-title":"Cell Cycle"},{"key":"1813_CR52","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a026104","volume":"6","author":"J Chen","year":"2016","unstructured":"Chen J. The Cell-Cycle Arrest and Apoptotic Functions of p53 in Tumor Initiation and Progression. Cold Spring Harb Perspect Med. 2016;6: a026104.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"1813_CR53","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.3389\/fonc.2020.01010","volume":"10","author":"UP Yadav","year":"2020","unstructured":"Yadav UP, Singh T, Kumar P, Sharma P, Kaur H, Sharma S, et al. Metabolic Adaptations in Cancer Stem Cells. Front Oncol. 2020;10:1010.","journal-title":"Front Oncol"},{"key":"1813_CR54","doi-asserted-by":"publisher","DOI":"10.1002\/wsbm.1595","volume":"15","author":"HM Begum","year":"2023","unstructured":"Begum HM, Shen K. Intracellular and microenvironmental regulation of mitochondrial membrane potential in cancer cells. WIREs Mechanisms of Disease. 2023;15: e1595.","journal-title":"WIREs Mechanisms of Disease"},{"key":"1813_CR55","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1023\/A:1022945107762","volume":"8","author":"JD Ly","year":"2003","unstructured":"Ly JD, Grubb DR, Lawen A. The mitochondrial membrane potential (\u0394\u03c8m) in apoptosis; an update. Apoptosis. 2003;8:115\u201328.","journal-title":"Apoptosis"},{"key":"1813_CR56","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1042\/bj3410233","volume":"341","author":"M Crompton","year":"1999","unstructured":"Crompton M. The mitochondrial permeability transition pore and its role in cell death. Biochemical Journal. 1999;341:233\u201349.","journal-title":"Biochemical Journal"},{"key":"1813_CR57","doi-asserted-by":"publisher","first-page":"285","DOI":"10.3389\/fonc.2014.00285","volume":"4","author":"J Pflaum","year":"2014","unstructured":"Pflaum J, Schlosser S, M\u00fcller M. p53 Family and Cellular Stress Responses in Cancer. Front Oncol. 2014;4:285.","journal-title":"Front Oncol"},{"key":"1813_CR58","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1182\/blood.V98.9.2603","volume":"98","author":"I Herr","year":"2001","unstructured":"Herr I, Debatin K-M. Cellular stress response and apoptosis in cancer therapy. Blood. 2001;98:2603\u201314.","journal-title":"Blood"},{"key":"1813_CR59","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/S1097-2765(03)00050-9","volume":"11","author":"M Mihara","year":"2003","unstructured":"Mihara M, Erster S, Zaika A, Petrenko O, Chittenden T, Pancoska P, et al. p53 Has a Direct Apoptogenic Role at the Mitochondria. Mol Cell. 2003;11:577\u201390.","journal-title":"Mol Cell"},{"key":"1813_CR60","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1038\/sj.embor.7400779","volume":"7","author":"E Szegezdi","year":"2006","unstructured":"Szegezdi E, Logue SE, Gorman AM, Samali A. Mediators of endoplasmic reticulum stress-induced apoptosis. EMBO Rep. 2006;7:880\u20135.","journal-title":"EMBO Rep"},{"key":"1813_CR61","doi-asserted-by":"publisher","first-page":"1112253","DOI":"10.3389\/fnmol.2023.1112253","volume":"16","author":"G Neill","year":"2023","unstructured":"Neill G, Masson GR. A stay of execution: ATF4 regulation and potential outcomes for the integrated stress response. Front Mol Neurosci. 2023;16:1112253.","journal-title":"Front Mol Neurosci"},{"key":"1813_CR62","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1038\/cdd.2017.82","volume":"24","author":"P Pih\u00e1n","year":"2017","unstructured":"Pih\u00e1n P, Carreras-Sureda A, Hetz C. BCL-2 family: integrating stress responses at the ER to control cell demise. Cell Death Differ. 2017;24:1478\u201387.","journal-title":"Cell Death Differ"},{"key":"1813_CR63","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1158\/2159-8290.CD-13-0136","volume":"4","author":"E Powell","year":"2014","unstructured":"Powell E, Piwnica-Worms D, Piwnica-Worms H. Contribution of p53 to metastasis. Cancer Discov. 2014;4:405\u201314.","journal-title":"Cancer Discov"},{"key":"1813_CR64","first-page":"933","volume":"102","author":"R Bagheri-Yarmand","year":"2017","unstructured":"Bagheri-Yarmand R, Williams MD, Grubbs EG, Gagel RF. ATF4 targets RET for degradation and is a candidate tumor suppressor gene in medullary thyroid cancer. J Clin Endocrinol Metab. 2017;102:933\u201341.","journal-title":"J Clin Endocrinol Metab"},{"key":"1813_CR65","doi-asserted-by":"publisher","first-page":"13042","DOI":"10.1038\/s41598-024-63895-y","volume":"14","author":"J Chen","year":"2024","unstructured":"Chen J, Huang X, Zhang S, Zhu X. ATF4 inhibits tumor development and mediates p-GCN2\/ASNS upregulation in colon cancer. Sci Rep. 2024;14:13042.","journal-title":"Sci Rep"},{"key":"1813_CR66","doi-asserted-by":"publisher","first-page":"6091","DOI":"10.1074\/jbc.M109.014092","volume":"285","author":"JL Armstrong","year":"2010","unstructured":"Armstrong JL, Flockhart R, Veal GJ, Lovat PE, Redfern CP. Regulation of endoplasmic reticulum stress-induced cell death by ATF4 in neuroectodermal tumor cells. J Biol Chem. 2010;285:6091\u2013100.","journal-title":"J Biol Chem"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-024-01813-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-024-01813-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-024-01813-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T09:06:33Z","timestamp":1726045593000},"score":1,"resource":{"primary":{"URL":"https:\/\/biosignaling.biomedcentral.com\/articles\/10.1186\/s12964-024-01813-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,11]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1813"],"URL":"https:\/\/doi.org\/10.1186\/s12964-024-01813-5","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,11]]},"assertion":[{"value":"1 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"437"}}